Fiona Trim
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
- Inflammatory Bowel Disease
Papers in
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 4
- Genetics 7
- Genetic Associations and Epidemiology 7
- Co-authors
- Nathan A. Moore (1 shared paper)Simon A. Weller (1 shared paper)Roman A. Lukaszewski (1 shared paper)Matthew W. Gilmour (1 shared paper)Thanh Le-Viet (1 shared paper)
- Journals
- JAMA (5 papers)Nature (4 papers)The Lancet (1 paper)Nature Communications (1 paper)Human Genetics and Genomics Advances (1 paper)
- Partner nations
- United KingdomSwedenItaly
In The Last Decade
Fiona Trim
15 papers receiving 2k citations
Fiona Trim's Hit Papers
Peers
Comparison fields: 5 of 90
- Infectious Diseases 1.2k
- Genetics 570
- Applied Microbiology and Biotechnology 33
- Neurology 91
- Internal Medicine 18
Countries citing papers authored by Fiona Trim
This map shows the geographic impact of Fiona Trim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Trim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Trim more than expected).
Fields of papers citing papers by Fiona Trim
This network shows the impact of papers produced by Fiona Trim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Trim. The network helps show where Fiona Trim may publish in the future.
Co-authors
The 5 scholars most cited alongside Fiona Trim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 4 | 2021 | 166 | |
| 5 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 6 | 2022 | 105 | |
| 7 | 2022 | 100 | |
| 8 | 2022 | 74 | |
| 9 | 2023 | 60 | |
| 10 | 2023 | 46 | |
| 11 | 2023 | 34 | |
| 12 | 2022 | 29 | |
| 13 | 2021 | 26 | |
| 14 | 2024 | 8 | |
| 15 | 2024 | 5 | |
| 16 | 2021 | 0 |
About Fiona Trim
Fiona Trim is a scholar working on Infectious Diseases, Genetics, Clinical Biochemistry, Nutrition and Dietetics and Nuclear Energy and Engineering, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Genetic Associations and Epidemiology (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Vitamin C and Antioxidants Research (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Infectious Diseases (1.2k citations), Genetics (570 citations), Applied Microbiology and Biotechnology (33 citations), Neurology (91 citations) and Internal Medicine (18 citations). Fiona Trim has collaborated with scholars based in United Kingdom, Sweden and Italy. Frequent co-authors include Nathan A. Moore, Simon A. Weller, Roman A. Lukaszewski, Matthew W. Gilmour and Thanh Le-Viet. Their work appears in journals such as JAMA, Nature, The Lancet, Nature Communications and Human Genetics and Genomics Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.